111 related articles for article (PubMed ID: 20090292)
1. Maternal serum ADAM-12 as a potential marker for different adverse pregnancy outcomes.
Matwejew E; Cowans NJ; Stamatopoulou A; Spencer K; von Kaisenberg CS
Fetal Diagn Ther; 2010; 27(1):32-9. PubMed ID: 20090292
[TBL] [Abstract][Full Text] [Related]
2. [Correlation of a disintegrin and metalloprotease 12 level in maternal serum during the first trimester with pregnancy outcome].
Qi H; Bian XM; Jiang YL; Liu SY; Guo Q
Zhonghua Fu Chan Ke Za Zhi; 2009 Jun; 44(6):401-4. PubMed ID: 19953936
[TBL] [Abstract][Full Text] [Related]
3. ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome.
Laigaard J; Spencer K; Christiansen M; Cowans NJ; Larsen SO; Pedersen BN; Wewer UM
Prenat Diagn; 2006 Oct; 26(10):973-9. PubMed ID: 16892462
[TBL] [Abstract][Full Text] [Related]
4. ADAM12s in maternal serum as a potential marker of pre-eclampsia.
Spencer K; Cowans NJ; Stamatopoulou A
Prenat Diagn; 2008 Mar; 28(3):212-6. PubMed ID: 18264967
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of biochemical marker ADAM-12 at first trimester of pregnancy for hypertension and intrauterine growth restriction.
Kasimis C; Evangelinakis N; Rotas M; Georgitsi M; Pelekanos N; Kassanos D
Clin Exp Obstet Gynecol; 2016; 43(1):43-7. PubMed ID: 27048016
[TBL] [Abstract][Full Text] [Related]
6. Maternal serum ADAM-12.
Wiwanitkit V
Fetal Diagn Ther; 2010; 27(4):236. PubMed ID: 20389056
[No Abstract] [Full Text] [Related]
7. ADAM 12 as a second-trimester maternal serum marker in screening for Down syndrome.
Christiansen M; Spencer K; Laigaard J; Cowans NJ; Larsen SO; Wewer UM
Prenat Diagn; 2007 Jul; 27(7):611-5. PubMed ID: 17465398
[TBL] [Abstract][Full Text] [Related]
8. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system.
Cowans NJ; Spencer K
Prenat Diagn; 2007 Mar; 27(3):264-71. PubMed ID: 17278174
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum disintegrin and metalloprotease protein-12 in early pregnancy as a potential marker of adverse pregnancy outcomes.
Yang J; Wu J; Guo F; Wang D; Chen K; Li J; Du L; Yin A
PLoS One; 2014; 9(5):e97284. PubMed ID: 24830297
[TBL] [Abstract][Full Text] [Related]
10. ADAM12 as a marker of trisomy 18 in the first and second trimester of pregnancy.
Spencer K; Cowans NJ
J Matern Fetal Neonatal Med; 2007 Sep; 20(9):645-50. PubMed ID: 17701664
[TBL] [Abstract][Full Text] [Related]
11. First trimester maternal serum ADAM12s levels in twin pregnancies.
Linskens IH; Twisk JW; Blankenstein MA; van Vugt JM
Prenat Diagn; 2010 Apr; 30(4):352-6. PubMed ID: 20187159
[TBL] [Abstract][Full Text] [Related]
12. First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome.
Poon LC; Chelemen T; Granvillano O; Pandeva I; Nicolaides KH
Obstet Gynecol; 2008 Nov; 112(5):1082-90. PubMed ID: 18978109
[TBL] [Abstract][Full Text] [Related]
13. First-trimester placental growth factor as a marker for hypertensive disorders and SGA.
Cowans NJ; Stamatopoulou A; Matwejew E; von Kaisenberg CS; Spencer K
Prenat Diagn; 2010 Jun; 30(6):565-70. PubMed ID: 20509158
[TBL] [Abstract][Full Text] [Related]
14. Maternal serum ADAM12s as a potential marker of trisomy 21 prior to 10 weeks of gestation.
Spencer K; Vereecken A; Cowans NJ
Prenat Diagn; 2008 Mar; 28(3):209-11. PubMed ID: 18264948
[TBL] [Abstract][Full Text] [Related]
15. First-trimester ADAM12s as early markers of trisomy 21: a promise still unfulfilled?
Spencer K; Cowans NJ; Uldbjerg N; Tørring N
Prenat Diagn; 2008 Apr; 28(4):338-42. PubMed ID: 18382998
[TBL] [Abstract][Full Text] [Related]
16. ADAM-12 stability in first trimester maternal serum.
Cowans NJ; Stamatopoulou A; Jaakohuhta S; Spencer K
Prenat Diagn; 2010 Jun; 30(6):555-60. PubMed ID: 20509156
[TBL] [Abstract][Full Text] [Related]
17. Maternal serum ADAM12s in the late first trimester of pregnancies with Trisomy 21.
Spencer K; Cowans NJ; Stamatopoulou A
Prenat Diagn; 2008 May; 28(5):422-4. PubMed ID: 18395873
[TBL] [Abstract][Full Text] [Related]
18. ADAM12s and PP13 as first trimester screening markers for adverse pregnancy outcome.
Deurloo KL; Linskens IH; Heymans MW; Heijboer AC; Blankenstein MA; van Vugt JM
Clin Chem Lab Med; 2013 Jun; 51(6):1279-84. PubMed ID: 23241612
[TBL] [Abstract][Full Text] [Related]
19. ADAM12 is an effective marker in the second trimester of pregnancy for prenatal screening of Down syndrome.
Wang M; Lu S; Zhu Y; Li H
Prenat Diagn; 2010 Jun; 30(6):561-4. PubMed ID: 20509157
[TBL] [Abstract][Full Text] [Related]
20. The value of early second trimester PAPP-A and ADAM12 in screening for pre-eclampsia.
Bestwick JP; George LM; Wu T; Morris JK; Wald NJ
J Med Screen; 2012 Mar; 19(1):51-4. PubMed ID: 22357350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
